Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Galapagos NV
  6. News
  7. Summary
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Galapagos : Deutsche Bank Initiates Coverage on Galapagos NV With Buy Rating

04/20/2021 | 08:56am EDT


ę MT Newswires 2021
All news about GALAPAGOS NV
07/15Galapagos ADRs Down After Study Data
DJ
07/15SECTOR UPDATE : Health Care Stocks Flat To Lower Pre-Bell Thursday
MT
07/15UPDATE : Galapagos Reports Results From Phase 1b Psoriasis Study -- Shares Slump..
MT
07/15GALAPAGOS : N.V., - Galapagos reports positive topline results with selective TY..
PU
07/15GALAPAGOS : N.V., - Galapagos demonstrates early clinical activity with SIK2/3 i..
PU
07/15GALAPAGOS : Drug Shown Safe In Three Clinical Studies
MT
07/15GALAPAGOS' : Psoriasis Drug Shown Safe, Well-Tolerated in Early-Stage Study
MT
07/14GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in infla..
PU
07/14GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3..
PU
07/14GALAPAGOS : GLPG3667 Shows Positive Results in Psoriasis Patients, Reports Topli..
MT
More news
Financials
Sales 2021 484 M 572 M 572 M
Net income 2021 -248 M -293 M -293 M
Net cash 2021 3 238 M 3 825 M 3 825 M
P/E ratio 2021 -13,8x
Yield 2021 -
Capitalization 3 333 M 3 937 M 3 937 M
EV / Sales 2021 0,20x
EV / Sales 2022 0,77x
Nbr of Employees 1 328
Free-Float 73,8%
Chart GALAPAGOS NV
Duration : Period :
Galapagos NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GALAPAGOS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 50,87 €
Average target price 73,11 €
Spread / Average Target 43,7%
EPS Revisions
Managers and Directors
Onno van de Stolpe Chief Executive Officer
Bart Filius President & Chief Operating Officer
Raj B. Parekh Chairman
Piet Wigerinck Chief Scientific Officer
Walid Abi-Saab Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GALAPAGOS NV-36.79%3 937
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.46%31 265
SEAGEN INC.-18.34%25 955